Start your Trading & Investing Journey with us
Join our channel for Daily Free Trades with Live analysis on Youtube, Trade Setup with Important Levels, and Important Stock Market Updates
Accretion Pharmaceuticals IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details
Accretion Pharmaceuticals IPO: Comprehensive Peer Comparison with Pharmaceutical Companies
This peer comparison evaluates Accretion Pharmaceuticals IPO against key competitors like Sakar Healthcare Limited, Lincoln Pharmaceuticals Limited and Sotac Pharmaceuticals Limited. By analysing essential financial metrics such as EPS, ROCE, ROE, P/E ratio, P/Bv, and Debt/Equity, investors can gain insights into the relative performance and valuation of these Pharmaceutical Company. This comparison highlights the strengths and positioning of Accretion Pharmaceuticals in the competitive landscape of the Pharmaceutical Industry.
Accretion Pharmaceuticals Limited IPO Peer Comparison
| Company Name | EPS | P/E (x) | ROE | ROCE | P/BV | Debt/Equity | RoNW (%) |
|---|---|---|---|---|---|---|---|
| Accretion Pharmaceuticals Limited | ₹ 3.49 | 28.97 | 70.47 % | 36.73 % | 5.91 | 2.52 | 70.47 % |
| Sakar Healthcare Limited | ₹ 6.81 | 39.8 | 5.28 % | 7.31 % | 2.20 | 0.28 | 5.28 % |
| Lincoln Pharmaceuticals Limited | ₹ 44.6 | 12.7 | 16.8 % | 22.3 % | 1.78 | 0.00 | 16.8 % |
| Sotac Pharmaceuticals Limited | ₹ 4.04 | 30.4 | 11.2 % | 10.0 % | 2.93 | 0.59 | 11.2 % |





